Adaptation and Evaluation of SHARE: A Palliative Care Intervention for Head and Neck Cancer Patients and their Caregivers

SHARE 的适应和评估:针对头颈癌患者及其护理人员的姑息治疗干预措施

基本信息

  • 批准号:
    10397122
  • 负责人:
  • 金额:
    $ 16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-04-23 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Many efficacious family-based interventions (FBIs) exist in cancer, but few have been integrated in routine care because they have not been designed/reported in a way that supports implementation. Barriers include resource- intensive designs that are incompatible with clinical workflows (e.g., multiple in-person visits or phone sessions with healthcare service providers) and a lack of healthcare reimbursement for services provided to caregivers. Making delivery channel adaptations could facilitate clinical uptake, and improve outcomes, but little guidance for adapting in-person/telephone-based FBIs for delivery via web/mobile platforms exists. This study uses Implementation Science (IS) and human-computer interaction principles to develop a model for adapting FBIs for digital delivery with the goal of improving uptake in oncology clinical care settings. We will adapt a highly promising telephone-based FBI called SHARE (Spouses coping with the Head and neck Radiation Experience) for delivery via mobile web (AIM 1), evaluate the feasibility, acceptability and non-inferiority of the new SHARE 2.0 prototype (AIM 2A), and elucidate factors that may influence implementation of SHARE 2.0 (AIM 2B). For AIM 1, we will adapt SHARE through collaborative efforts by assembling a stakeholder advisory committee (SAC) of 6 HNC patients and 6 caregivers to provide feedback on unadapted SHARE materials and desired technical features of SHARE 2.0 to inform an adaptation blueprint. Next, we will apply the Accelerated Creation-to- Sustainment (ACTS) model to iteratively develop SHARE 2.0 followed by usability testing with 5 patients and 5 caregivers. The outcome will be a functional prototype that is free from significant usability errors. For AIM 2A, we will conduct a single-arm trial of SHARE 2.0 with 65 patient-caregiver dyads. Participants complete surveys before initiating external beam radiation therapy (EBRT) and 1 month post-EBRT. We will judge the trial feasible and acceptable if results are consistent with at least 70% of eligible patients/caregivers enrolling and at least 80% reporting satisfaction with content/logistics. We will also examine whether SHARE 2.0 performs comparably to SHARE by comparing findings from this trial to the results of the original SHARE pilot trial. For AIM 2B, we will apply the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) QuEST (Qualitative Evaluation for Systematic Translation) mixed-methods framework to identify individual/organizational factors that may influence future adoption, implementation, and sustainability of SHARE 2.0 before proceeding to a hybrid implementation-effectiveness trial. Overall, this study will yield a functioning technology-enabled intervention that delivers symptom-management support, and meets the needs of stakeholders, thereby maximizing likelihood of uptake and sustainability in oncology clinical care. If successful, it could serve as a model for adapting other FBIs for digital delivery and improve palliative and supportive care delivery in cancer.
项目概要 许多有效的基于家庭的干预措施 (FBI) 存在于癌症治疗中,但很少被纳入日常护理中 因为它们的设计/报告方式并未支持实施。障碍包括资源- 与临床工作流程不兼容的密集设计(例如,多次亲自就诊或电话会议 与医疗保健服务提供者)以及缺乏向护理人员提供的服务的医疗保健报销。 调整输送渠道可以促进临床应用并改善结果,但指导很少 现有用于调整面对面/基于电话的 FBI 以便通过网络/移动平台进行交付的方法。本研究使用 实施科学 (IS) 和人机交互原理,用于开发适应 FBI 的模型 用于数字化交付,旨在提高肿瘤临床护理环境的采用率。我们将采用高度 有前途的基于电话的联邦调查局称为SHARE(配偶应对头颈辐射经历) 通过移动网络交付(AIM 1),评估新 SHARE 的可行性、可接受性和非劣效性 2.0 原型(AIM 2A),并阐明可能影响 SHARE 2.0 实施的因素(AIM 2B)。为了 目标 1,我们将通过组建利益相关者咨询委员会 (SAC) 的协作努力来调整 SHARE 6 名 HNC 患者和 6 名护理人员提供有关未改编的 SHARE 材料和所需技术的反馈 SHARE 2.0 的功能为适应蓝图提供信息。接下来,我们将应用加速创建- 维持 (ACTS) 模型迭代开发 SHARE 2.0,然后对 5 名患者和 5 名患者进行可用性测试 照顾者。结果将是一个没有重大可用性错误的功能原型。对于 AIM 2A, 我们将对 65 名患者-护理人员进行单组 SHARE 2.0 试验。参与者完成调查 开始外照射放射治疗 (EBRT) 之前和 EBRT 后 1 个月。我们将判断试验是否可行 如果结果与至少 70% 的合格患者/护理人员注册一致且至少是可接受的 80% 的人对内容/后勤表示满意。我们还将检验 SHARE 2.0 的表现是否具有可比性 通过将该试验的结果与最初的 SHARE 试点试验的结果进行比较来分享。对于 AIM 2B,我们 将应用 RE-AIM(范围、有效性、采用、实施、维护)QuEST(定性 系统翻译评估)混合方法框架来识别个人/组织因素 在进行混合之前可能会影响 SHARE 2.0 未来的采用、实施和可持续性 实施效果试验。总体而言,这项研究将产生一种有效的技术干预措施, 提供症状管理支持,并满足利益相关者的需求,从而最大限度地提高 肿瘤临床护理的吸收和可持续性。如果成功,它可以作为适应其他 FBI 用于数字化交付并改善癌症的姑息治疗和支持性护理服务。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hoda J Badr其他文献

Hoda J Badr的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hoda J Badr', 18)}}的其他基金

OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
OPTIMISE:一种共享护理方法,可在安全网系统中改善患有合并症的癌症患者的综合护理
  • 批准号:
    10408739
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
OPTIMISE:一种共享护理方法,可在安全网系统中改善患有合并症的癌症患者的综合护理
  • 批准号:
    10175490
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System
OPTIMISE:一种共享护理方法,可在安全网系统中改善患有合并症的癌症患者的综合护理
  • 批准号:
    10643856
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
Adaptation and Evaluation of SHARE: A Palliative Care Intervention for Head and Neck Cancer Patients and their Caregivers
SHARE 的适应和评估:针对头颈癌患者及其护理人员的姑息治疗干预措施
  • 批准号:
    10216592
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
Supplement: Effects of Comorbidity Management and Complex Care Coordination on Cancer Caregivers
补充:合并症管理和复杂护理协调对癌症护理人员的影响
  • 批准号:
    10818788
  • 财政年份:
    2021
  • 资助金额:
    $ 16万
  • 项目类别:
Improving Self-management in Head and Neck Cancer
改善头颈癌的自我管理
  • 批准号:
    9337152
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
Improving Self-management in Head and Neck Cancer
改善头颈癌的自我管理
  • 批准号:
    8752355
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
针对晚期肺癌患者护理人员的心理社会干预
  • 批准号:
    8748544
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
针对晚期肺癌患者护理人员的心理社会干预
  • 批准号:
    9326815
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:
A Psychosocial Intervention for the Caregivers of Advanced Lung Cancer Patients
针对晚期肺癌患者护理人员的心理社会干预
  • 批准号:
    8906834
  • 财政年份:
    2014
  • 资助金额:
    $ 16万
  • 项目类别:

相似海外基金

Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 16万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 16万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了